Autonomix Medical Inc (AMIX) 成功获得一项美国新专利,此举显著增强了其下一代精准神经调控技术平台的知识产权壁垒。这项专利授权为公司前沿的神经调控解决方案提供了关键的法律保护,巩固了其在开发靶向、微创治疗慢性疼痛及相关神经系统疾病领域的竞争优势。
Autonomix Medical Inc (AMIX) 成功获得一项美国新专利,此举显著增强了其下一代精准神经调控技术平台的知识产权壁垒。这项专利授权为公司前沿的神经调控解决方案提供了关键的法律保护,巩固了其在开发靶向、微创治疗慢性疼痛及相关神经系统疾病领域的竞争优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.